Which has better earnings and valuation, ADUS or HNGE?

Addus HomeCare has higher revenue and earnings than Hinge Health. Addus HomeCare is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Addus HomeCare $1.42B 1.56 $95.91M $5.70 20.83 Hinge Health $587.86M 12.51 -$528.26M $1.28 71.18

Does the media favor ADUS or HNGE?

In the previous week, Addus HomeCare had 3 more articles in the media than Hinge Health. MarketBeat recorded 13 mentions for Addus HomeCare and 10 mentions for Hinge Health. Addus HomeCare's average media sentiment score of 1.41 beat Hinge Health's score of 0.53 indicating that Addus HomeCare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Addus HomeCare 9 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Hinge Health 6 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation & earnings, ADUS or CHE?

Chemed has higher revenue and earnings than Addus HomeCare. Addus HomeCare is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Addus HomeCare $1.42B 1.56 $95.91M $5.70 20.83 Chemed $2.53B 2.70 $265.24M $19.91 26.26

Does the media refer more to ADUS or CHE?

In the previous week, Chemed had 4 more articles in the media than Addus HomeCare. MarketBeat recorded 17 mentions for Chemed and 13 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 1.41 beat Chemed's score of 1.01 indicating that Addus HomeCare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Addus HomeCare 9 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Chemed 14 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor HIMS or ADUS?

In the previous week, Hims & Hers Health had 17 more articles in the media than Addus HomeCare. MarketBeat recorded 30 mentions for Hims & Hers Health and 13 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 1.41 beat Hims & Hers Health's score of 0.17 indicating that Addus HomeCare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 4 Very Positive mention(s) 7 Positive mention(s) 11 Neutral mention(s) 5 Negative mention(s) 1 Very Negative mention(s) Neutral Addus HomeCare 9 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Is ADUS or RDNT more profitable?

Addus HomeCare has a net margin of 7.13% compared to RadNet's net margin of -0.93%. Addus HomeCare's return on equity of 9.96% beat RadNet's return on equity. Company Net Margins Return on Equity Return on Assets Addus HomeCare 7.13% 9.96% 7.62% RadNet -0.93% 2.61% 0.91%

Does the media refer more to ADUS or RDNT?

In the previous week, RadNet had 1 more articles in the media than Addus HomeCare. MarketBeat recorded 14 mentions for RadNet and 13 mentions for Addus HomeCare. RadNet's average media sentiment score of 1.71 beat Addus HomeCare's score of 1.41 indicating that RadNet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Addus HomeCare 9 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive RadNet 13 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media favor ADUS or LFST?

In the previous week, Addus HomeCare had 5 more articles in the media than LifeStance Health Group. MarketBeat recorded 13 mentions for Addus HomeCare and 8 mentions for LifeStance Health Group. Addus HomeCare's average media sentiment score of 1.41 beat LifeStance Health Group's score of 0.92 indicating that Addus HomeCare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Addus HomeCare 9 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive LifeStance Health Group 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Addus HomeCare (ADUS) Competitors

$118.74 -1.97 (-1.63%)

As of 09:30 AM Eastern

Compare

ADUS vs. HNGE, CHE, HIMS, RDNT, and LFST

Should you buy Addus HomeCare stock or one of its competitors? Addus HomeCare's main competitors and comparable companies include Hinge Health (HNGE), Chemed (CHE), Hims & Hers Health (HIMS), RadNet (RDNT), and LifeStance Health Group (LFST). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Addus HomeCare compare to Hinge Health?

Addus HomeCare (NASDAQ:ADUS) and Hinge Health (NYSE:HNGE) are both mid-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, dividends, risk and analyst recommendations.

Hinge Health has a net margin of 15.15% compared to Addus HomeCare's net margin of 7.13%. Hinge Health's return on equity of 51.60% beat Addus HomeCare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	7.13%	9.96%	7.62%
Hinge Health	15.15%	51.60%	14.16%

95.4% of Addus HomeCare shares are held by institutional investors. 4.1% of Addus HomeCare shares are held by insiders. Comparatively, 18.9% of Hinge Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Addus HomeCare currently has a consensus price target of $130.88, suggesting a potential upside of 10.22%. Hinge Health has a consensus price target of $100.57, suggesting a potential upside of 10.38%. Given Hinge Health's stronger consensus rating and higher probable upside, analysts plainly believe Hinge Health is more favorable than Addus HomeCare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73
Hinge Health	1 Sell rating(s)	2 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.83

In the previous week, Addus HomeCare had 3 more articles in the media than Hinge Health. MarketBeat recorded 13 mentions for Addus HomeCare and 10 mentions for Hinge Health. Addus HomeCare's average media sentiment score of 1.41 beat Hinge Health's score of 0.53 indicating that Addus HomeCare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Addus HomeCare	9 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Hinge Health	6 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Addus HomeCare has higher revenue and earnings than Hinge Health. Addus HomeCare is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$1.42B	1.56	$95.91M	$5.70	20.83
Hinge Health	$587.86M	12.51	-$528.26M	$1.28	71.18

Addus HomeCare has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market. Comparatively, Hinge Health has a beta of 1.3, indicating that its stock price is 30% more volatile than the broader market.

Summary

Hinge Health beats Addus HomeCare on 10 of the 16 factors compared between the two stocks.

How does Addus HomeCare compare to Chemed?

Addus HomeCare (NASDAQ:ADUS) and Chemed (NYSE:CHE) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability.

Addus HomeCare has a beta of 0.87, meaning that its stock price is 13% less volatile than the broader market. Comparatively, Chemed has a beta of 0.51, meaning that its stock price is 49% less volatile than the broader market.

95.4% of Addus HomeCare shares are held by institutional investors. Comparatively, 95.9% of Chemed shares are held by institutional investors. 4.1% of Addus HomeCare shares are held by insiders. Comparatively, 3.3% of Chemed shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Chemed has a net margin of 10.60% compared to Addus HomeCare's net margin of 7.13%. Chemed's return on equity of 31.77% beat Addus HomeCare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	7.13%	9.96%	7.62%
Chemed	10.60%	31.77%	18.90%

Chemed has higher revenue and earnings than Addus HomeCare. Addus HomeCare is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$1.42B	1.56	$95.91M	$5.70	20.83
Chemed	$2.53B	2.70	$265.24M	$19.91	26.26

Addus HomeCare currently has a consensus price target of $130.88, suggesting a potential upside of 10.22%. Chemed has a consensus price target of $530.75, suggesting a potential upside of 1.52%. Given Addus HomeCare's stronger consensus rating and higher possible upside, analysts plainly believe Addus HomeCare is more favorable than Chemed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73
Chemed	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17

In the previous week, Chemed had 4 more articles in the media than Addus HomeCare. MarketBeat recorded 17 mentions for Chemed and 13 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 1.41 beat Chemed's score of 1.01 indicating that Addus HomeCare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Addus HomeCare	9 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Chemed	14 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Chemed beats Addus HomeCare on 10 of the 17 factors compared between the two stocks.

How does Addus HomeCare compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Addus HomeCare (NASDAQ:ADUS) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk, analyst recommendations and media sentiment.

Hims & Hers Health currently has a consensus price target of $32.50, indicating a potential upside of 4.87%. Addus HomeCare has a consensus price target of $130.88, indicating a potential upside of 10.22%. Given Addus HomeCare's stronger consensus rating and higher probable upside, analysts plainly believe Addus HomeCare is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19
Addus HomeCare	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73

Hims & Hers Health has higher revenue and earnings than Addus HomeCare. Hims & Hers Health is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	3.08	$128.37M	-$0.63	N/A
Addus HomeCare	$1.42B	1.56	$95.91M	$5.70	20.83

In the previous week, Hims & Hers Health had 17 more articles in the media than Addus HomeCare. MarketBeat recorded 30 mentions for Hims & Hers Health and 13 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 1.41 beat Hims & Hers Health's score of 0.17 indicating that Addus HomeCare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	4 Very Positive mention(s)	7 Positive mention(s)	11 Neutral mention(s)	5 Negative mention(s)	1 Very Negative mention(s)	Neutral
Addus HomeCare	9 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 95.4% of Addus HomeCare shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by company insiders. Comparatively, 4.1% of Addus HomeCare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Addus HomeCare has a net margin of 7.13% compared to Hims & Hers Health's net margin of -5.51%. Addus HomeCare's return on equity of 9.96% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-5.51%	-6.51%	-1.20%
Addus HomeCare	7.13%	9.96%	7.62%

Hims & Hers Health has a beta of 2.4, suggesting that its stock price is 140% more volatile than the broader market. Comparatively, Addus HomeCare has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market.

Summary

Addus HomeCare beats Hims & Hers Health on 11 of the 17 factors compared between the two stocks.

How does Addus HomeCare compare to RadNet?

Addus HomeCare (NASDAQ:ADUS) and RadNet (NASDAQ:RDNT) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, dividends, valuation and earnings.

Addus HomeCare has a net margin of 7.13% compared to RadNet's net margin of -0.93%. Addus HomeCare's return on equity of 9.96% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	7.13%	9.96%	7.62%
RadNet	-0.93%	2.61%	0.91%

Addus HomeCare currently has a consensus price target of $130.88, indicating a potential upside of 10.22%. RadNet has a consensus price target of $88.00, indicating a potential upside of 16.22%. Given RadNet's stronger consensus rating and higher possible upside, analysts plainly believe RadNet is more favorable than Addus HomeCare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73
RadNet	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.89

95.4% of Addus HomeCare shares are held by institutional investors. Comparatively, 77.9% of RadNet shares are held by institutional investors. 4.1% of Addus HomeCare shares are held by company insiders. Comparatively, 5.1% of RadNet shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Addus HomeCare has higher earnings, but lower revenue than RadNet. RadNet is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$1.42B	1.56	$95.91M	$5.70	20.83
RadNet	$2.27B	2.63	-$18.65M	-$0.27	N/A

In the previous week, RadNet had 1 more articles in the media than Addus HomeCare. MarketBeat recorded 14 mentions for RadNet and 13 mentions for Addus HomeCare. RadNet's average media sentiment score of 1.71 beat Addus HomeCare's score of 1.41 indicating that RadNet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Addus HomeCare	9 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
RadNet	13 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Addus HomeCare has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market. Comparatively, RadNet has a beta of 1.36, indicating that its stock price is 36% more volatile than the broader market.

Summary

RadNet beats Addus HomeCare on 9 of the 17 factors compared between the two stocks.

How does Addus HomeCare compare to LifeStance Health Group?

Addus HomeCare (NASDAQ:ADUS) and LifeStance Health Group (NASDAQ:LFST) are both mid-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, profitability, dividends and earnings.

95.4% of Addus HomeCare shares are owned by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are owned by institutional investors. 4.1% of Addus HomeCare shares are owned by insiders. Comparatively, 3.5% of LifeStance Health Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Addus HomeCare has a net margin of 7.13% compared to LifeStance Health Group's net margin of 3.19%. Addus HomeCare's return on equity of 9.96% beat LifeStance Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	7.13%	9.96%	7.62%
LifeStance Health Group	3.19%	3.39%	2.33%

In the previous week, Addus HomeCare had 5 more articles in the media than LifeStance Health Group. MarketBeat recorded 13 mentions for Addus HomeCare and 8 mentions for LifeStance Health Group. Addus HomeCare's average media sentiment score of 1.41 beat LifeStance Health Group's score of 0.92 indicating that Addus HomeCare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Addus HomeCare	9 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
LifeStance Health Group	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Addus HomeCare has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.14, indicating that its share price is 14% more volatile than the broader market.

Addus HomeCare has higher earnings, but lower revenue than LifeStance Health Group. Addus HomeCare is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$1.42B	1.56	$95.91M	$5.70	20.83
LifeStance Health Group	$1.58B	3.03	$9.66M	$0.13	95.31

Addus HomeCare presently has a consensus target price of $130.88, indicating a potential upside of 10.22%. LifeStance Health Group has a consensus target price of $12.38, indicating a potential downside of 0.12%. Given Addus HomeCare's higher probable upside, equities analysts clearly believe Addus HomeCare is more favorable than LifeStance Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73

Summary

Addus HomeCare beats LifeStance Health Group on 11 of the 15 factors compared between the two stocks.

Get Addus HomeCare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ADUS vs. The Competition

Export

Metric	Addus HomeCare	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.22B	$10.04B	$7.32B	$12.79B
Dividend Yield	N/A	2.55%	2.53%	11.02%
P/E Ratio	20.83	35.06	271.28	25.69
Price / Sales	1.56	5.07	693.41	127.06
Price / Cash	18.59	126.73	79.17	53.57
Price / Book	1.93	4.10	13.02	6.26
Net Income	$95.91M	$312.92M	$3.46B	$348.07M
7 Day Performance	-1.71%	-0.40%	1.01%	0.47%
1 Month Performance	-0.40%	0.28%	8.62%	5.19%
1 Year Performance	2.97%	16.59%	26.56%	16.68%

Addus HomeCare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ADUS Addus HomeCare	4.0225 of 5 stars	$118.74 -1.6%	$130.88 +10.2%	+2.2%	$2.22B	$1.42B	20.83	50,659	Positive News
HNGE Hinge Health	3.6737 of 5 stars	$89.25 +1.6%	$100.57 +12.7%	+60.5%	$7.18B	$720.06M	69.48	1,437
CHE Chemed	3.6324 of 5 stars	$537.53 +2.4%	$530.75 -1.3%	+13.9%	$7.03B	$2.53B	27.01	15,811	Positive News Gap Up
HIMS Hims & Hers Health	1.6485 of 5 stars	$28.22 -1.4%	$32.43 +14.9%	-28.2%	$6.56B	$2.58B	N/A	2,442
RDNT RadNet	3.9378 of 5 stars	$74.74 -1.6%	$88.00 +17.7%	+5.7%	$5.88B	$2.04B	N/A	11,264	Positive News Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ADUS) was last updated on 8/28/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Addus HomeCare (ADUS) Competitors

ADUS vs. HNGE, CHE, HIMS, RDNT, and LFST

How does Addus HomeCare compare to Hinge Health?

Summary

How does Addus HomeCare compare to Chemed?

Summary

How does Addus HomeCare compare to Hims & Hers Health?

Summary

How does Addus HomeCare compare to RadNet?

Summary

How does Addus HomeCare compare to LifeStance Health Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADUS vs. The Competition

Addus HomeCare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Addus HomeCare (ADUS) Competitors

ADUS vs. HNGE, CHE, HIMS, RDNT, and LFST

How does Addus HomeCare compare to Hinge Health?

Is ADUS or HNGE more profitable?

Do institutionals & insiders have more ownership in ADUS or HNGE?

Do analysts rate ADUS or HNGE?

Does the media favor ADUS or HNGE?

Which has better earnings and valuation, ADUS or HNGE?

Which has more volatility & risk, ADUS or HNGE?

Summary

How does Addus HomeCare compare to Chemed?

Which has more risk and volatility, ADUS or CHE?

Do institutionals & insiders hold more shares of ADUS or CHE?

Is ADUS or CHE more profitable?

Which has higher valuation & earnings, ADUS or CHE?

Do analysts prefer ADUS or CHE?

Does the media refer more to ADUS or CHE?

Summary

How does Addus HomeCare compare to Hims & Hers Health?

Do analysts recommend HIMS or ADUS?

Which has stronger valuation & earnings, HIMS or ADUS?

Does the media favor HIMS or ADUS?

Do insiders & institutionals believe in HIMS or ADUS?

Is HIMS or ADUS more profitable?

Which has more risk and volatility, HIMS or ADUS?

Summary

How does Addus HomeCare compare to RadNet?

Is ADUS or RDNT more profitable?

Do analysts rate ADUS or RDNT?

Do institutionals & insiders have more ownership in ADUS or RDNT?

Which has better earnings and valuation, ADUS or RDNT?

Does the media refer more to ADUS or RDNT?

Which has more volatility and risk, ADUS or RDNT?

Summary

How does Addus HomeCare compare to LifeStance Health Group?

Do institutionals and insiders have more ownership in ADUS or LFST?

Is ADUS or LFST more profitable?

Does the media favor ADUS or LFST?

Which has more risk & volatility, ADUS or LFST?

Which has stronger earnings & valuation, ADUS or LFST?

Do analysts recommend ADUS or LFST?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADUS vs. The Competition

Addus HomeCare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools